1. Broca, P. (1866). Traite des tumours. Des Tumeurs en General. Vol. 1. (Paris: Anselin, Becket et Labe)
2. de Gouvea, H. (1896). Bull. Soc. Med. Chir., 8, 25
3. Sedgwick, R. P. and Boder, E. S. (1972). Ataxia-telangiectasia. In Vinken, P. J. and Breyer, G. W. (eds.) Handbook of Clinical Neurology, pp. 317–318. (Amsterdam: North Holland)
4. Hecht, F. and Kaiser-Maw, B. (1982). Ataxia-telangiectasia: genetics and heterogeneity. In Bridges, B. A. and Harnden, D. G. (eds.) Ataxia-telangiectasia. A Cellular and Molecular Link between Cancer, Neuropathology, and Immune Deficiency, pp. 197–201. (Chichester: John Wiley & Sons)
5. Filipovich, A. H., Spector, B. D. and Kersey, J. H. (1980). Immunodeficiency in humans as a risk factor in the development of malignancy. Prev. Med., 9, 252–259